{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:21Z","timestamp":1786649961490,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anti-M antibody is one of the causes of severe fetal anemia and intrauterine death despite its relatively low frequency. A G3P2 26-year-old pregnant woman referred to our hospital at 29 weeks gestational age (WGA) with fetal hydrops. Her second pregnancy results in intrauterine fetal death at 35 WGA due to fetal hydrops. From ultrasound exam, we found singleton live fetus with ascites, cardiomegaly, and pericardial effusion. The peak systolic velocity in the fetal middle cerebral artery (PSV-MCA) was 1.44 multiples of the median corresponding to fetal anemia. The patient\u2019s blood group was B RhD+M\u2212 N+. A reactive IgG anti-M antibody was detected at 37\u00b0C. Fetal hemoglobin (Hb) from the first cordocentesis was 2.2 g\/dl and we perform multiple intrauterine transfusions and cesarean section at 34 WGA. The postdelivery Hb level was 10.2 g\/dl and infant need three times packed red blood cell transfusions after delivery.<\/jats:p>","DOI":"10.4103\/ajts.ajts_71_22","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T04:48:23Z","timestamp":1664254103000},"page":"326-329","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Serial intrauterine transfusion for severe fetal anemia due to anti-M alloimmunization"],"prefix":"10.4103","volume":"18","author":[{"given":"Rachmat Dediat","family":"Kapnosa Hasani","sequence":"first","affiliation":[{"name":"Indonesia National Center for Maternal and Children Health, Harapan Kita Mother and Children Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gatot","family":"Abdurazak","sequence":"additional","affiliation":[{"name":"Indonesia National Center for Maternal and Children Health, Harapan Kita Mother and Children Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adhi","family":"Pribadi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine Padjajaran University, Hasan Sadikin General Hospital, Bandung, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"R1-20241224","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/trf.15054","article-title":"Hemolytic disease of the fetus and newborn due to alloanti-M: Three Chinese case reports and a review of the literature","volume":"59","author":"Li","year":"2019","journal-title":"Transfusion"},{"key":"R2-20241224","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tjog.2017.04.022","article-title":"Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions","volume":"56","author":"Li","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"bcr2014203534","DOI":"10.1136\/bcr-2014-203534","article-title":"Anti-M antibodies as a cause of intrauterine fetal death and neonatal hyperbilirubinaemia","author":"Sharma","year":"2014","journal-title":"BMJ Case Rep 2014"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"102949","DOI":"10.1016\/j.transci.2020.102949","article-title":"Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases","volume":"59","author":"Ohto","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"R6-20241224","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1055\/s-0037-1607028","article-title":"Anti-M alloimmunization: Management and outcome at a single institution","volume":"7","author":"Stetson","year":"2017","journal-title":"AJP Rep"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2013.10.002","article-title":"Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: A case report and review of the Japanese literature","volume":"28","author":"Yasuda","year":"2014","journal-title":"Transfus Med Rev"},{"key":"R8-20241224","doi-asserted-by":"crossref","first-page":"e230552","DOI":"10.1136\/bcr-2019-230552","article-title":"Recurrent fetal hydrops with maternal M alloimmunisation: Not a benign condition","volume":"12","author":"Yu","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/pd.1679","article-title":"Successful treatment of fetal erythroblastosis due to anti-M alloimmunization with fetal intravascular transfusion","volume":"27","author":"Seo","year":"2007","journal-title":"Prenat Diagn"},{"key":"R11-20241224","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1537-2995.2007.01209.x","article-title":"Fetal hemolytic anemia and intrauterine death caused by anti-M immunization","volume":"47","author":"Wikman","year":"2007","journal-title":"Transfusion"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0973-6247.150968","article-title":"Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins","volume":"9","author":"Arora","year":"2015","journal-title":"Asian J Transfus Sci"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_71_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:24Z","timestamp":1786647624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_71_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_71_22","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"2022-06-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}